Fasting C-Peptide Index May be the Strongest Predictor for Detecting Effectiveness of Glycemic Control by GLP-1 Analogue, Liraglutide Therapy for Japanese Type 2 Diabetic Patients

Tetsuo Nishikawa
Yoko Matsuzawa, Takumi Kitamoto and Tetsuo Nishikawa*
Article information